ea0090p656 | Endocrine-related Cancer | ECE2023
Hubalewska-Dydejczyk Alicja
, Decristoforo Clemens
, Kolenc Petra
, Mikolajczak Renata
, Ležaić Luka
, Suden Andrej
, Garnuszek Piotr
, Simoncic Urban
, Virgolini Irene
, Trofimiuk-Muldner Malgorzata
, Opalinska Marta
, Rangger Christine
, Glowa Boguslaw
, Skorkiewicz Konrad
, Fani Melpomeni
, Sowa Staszczak Anna
, Janota Barbara
, Kroselj Marko
, Zaletel Katja
, Von Guggenberg Elisabeth
Introduction: The management of patients with neuroendocrine neoplasms (NEN) has been revolutionised since the introduction of radiolabelled somatostatin analogues targeting overexpressed somatostatin receptors (SSTR). Accurate assessment of SSTR status of primary focus/metastases is crucial to determine the choice of the treatment method. Recently it has been shown that novel molecular probes, SST2-antagonists, recognize more binding sites in comparison to the wide...